# AVALIDE
> **NDA020758** · New Drug Application · Sponsor: SANOFI AVENTIS US · Approved 1997-09-30
## Drug
- **FDA Application Number:** NDA020758
- **Application type:** New Drug Application
- **Brand name:** AVALIDE
- **Generic name:** IRBESARTAN AND HYDROCHLOROTHIAZIDE
- **Active ingredients:** HYDROCHLOROTHIAZIDE; IRBESARTAN
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** SANOFI AVENTIS US
- **Manufacturer:** Sanofi-Aventis U.S. LLC
- **First approval:** 1997-09-30
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=020758)
---
*MORVS · CC0 1.0*